Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203385 · ClinicalTrials.gov registry record · Phase 4
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
A Phase 4 study, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00203385: Clinical Trial Phase 4 study, sponsored by Tuscaloosa Research & Education Advancement Corporation.
NCT00203385 is a Phase 4 study that was terminated before completion, run by Tuscaloosa Research & Education Advancement Corporation. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00203385, a Phase 4 study, was terminated before completion, sponsored by Tuscaloosa Research & Education Advancement Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.
Primary Outcome
Clinician-administered rating scale to assess PTSD, 17-items, higher score is more severe, range from zero to 136
Interventions
- DRUG Divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-03 |
| Phase | Phase 4 |
Why NCT00203385 stopped before completion
NCT00203385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Divalproex is the first listed.
NCT00203385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00203385 about?
NCT00203385 is a clinical study titled "Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder". The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.
What is the current status of trial NCT00203385?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2003-05. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00203385?
The interventions under investigation include: Divalproex (DRUG).
Who is sponsoring clinical trial NCT00203385?
This trial is sponsored by Tuscaloosa Research & Education Advancement Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00203385's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia